SCLN
Sciclone Pharmaceuticals Inc
SCLN
SCLN
Delisted
SCLN was delisted on the 13th of October, 2017.
153 hedge funds and large institutions have $396M invested in Sciclone Pharmaceuticals Inc in 2016 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 55 increasing their positions, 49 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% more funds holding
Funds holding: 151 → 153 (+2)
0% less capital invested
Capital invested by funds: $396M → $396M (-$505K)
Holders
153
Holding in Top 10
2
Calls
$290K
Puts
$45K
Top Buyers
| 1 | +$13.5M | |
| 2 | +$5.04M | |
| 3 | +$4.31M | |
| 4 |
Renaissance Technologies
New York
|
+$4.16M |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$2M |
Top Sellers
| 1 | -$17.5M | |
| 2 | -$14.2M | |
| 3 | -$4.31M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$3.28M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$3.24M |